QLT discloses results from phase IIa trial of QLT-091001 in impaired dark adaptation Dec. 10, 2014 No Comments
Launch of Glanatek Ophthalmic Solution, a new treatment for glaucoma and ocular hypertension Dec. 4, 2014 No Comments
Amarantus reports preclinical data on MANF in a model of retinitis pigmentosa Nov. 27, 2014 No Comments
Ocata granted European ATMP designation for RPE program for macular degeneration Nov. 26, 2014 No Comments
EMA committee recommends approval of Travatan for use in pediatric patients Nov. 25, 2014 No Comments
RSS